Legend Biotech Ownership | Who Owns Legend Biotech?


OverviewForecastChartTranscripts

Legend Biotech Ownership Summary


Legend Biotech is owned by 14.81% institutional investors, 1.31% insiders, and 83.88% retail investors. Fmr is the largest institutional shareholder, holding 13.91% of LEGN shares. Fidelity OTC is the top mutual fund, with 2.53% of its assets in Legend Biotech shares.

LEGN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLegend Biotech14.81%1.31%83.88%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr25.70M13.91%$464.85M
Deerfield management company, l.p. (series c)7.69M4.16%$139.07M
Suvretta capital management7.58M4.10%$137.14M
Hhlr advisors5.98M3.24%$108.26M
Blackrock5.72M3.14%$253.40M
Westfield capital management co lp5.76M3.12%$104.26M
Blackrock funding, inc. /de4.68M2.54%$84.74M
Point72 asset management3.89M2.10%$70.30M
First beijing investment2.30M1.24%$41.54M
Artisan partners limited partnership2.25M1.22%$40.78M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ivyrock asset management (hk)804.00K8.17%$14.54M
Matthews capital management925.92K6.80%$16.75M
Davern capital partners, lp1.31M6.52%$23.78M
Hhlr advisors5.98M6.47%$108.26M
Suvretta capital management7.58M3.50%$137.14M
Patient square capital lp990.00K3.18%$17.91M
Johnson & johnson814.59K2.26%$14.74M
Allostery investments lp4.00K1.81%$141.96K
First beijing investment2.30M1.79%$41.54M
Kynam capital management, lp1.58M1.76%$28.52M

Top Buyers

HolderShares% AssetsChange
First beijing investment2.30M1.79%2.30M
Deerfield management company, l.p. (series c)7.69M1.64%1.76M
Kynam capital management, lp1.58M1.76%1.58M
Fmr25.70M0.02%1.43M
Two sigma investments, lp1.89M0.03%1.36M

Top Sellers

HolderShares% AssetsChange
Ra capital management---7.51M
Capital world investors---2.39M
Wellington management group llp---1.86M
Alliancebernstein---1.52M
Braidwell lp---1.30M

New Positions

HolderShares% AssetsChangeValue
First beijing investment2.30M1.79%2.30M$41.54M
Kynam capital management, lp1.58M1.76%1.58M$28.52M
Patient square capital lp990.00K3.18%990.00K$17.91M
Rakuten investment management232.47K0.02%232.47K$6.60M
Y-intercept (hong kong)223.30K0.08%223.30K$4.04M

Sold Out

HolderChange
Larson financial group-2.00
Abound wealth management-4.00
Cva family office-15.00
Smartleaf asset management-21.00
Parkside financial bank & trust-23.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026119-44.65%27,360,336-68.76%140.16%63-40.57%30-53.13%
Dec 31, 2025139-35.65%28,301,091-66.19%310.38%66-40.00%41-28.07%
Sep 30, 2025208-7.56%83,554,687-1.27%904.30%104-4.59%57-32.94%
Jun 30, 20252242.75%84,632,757-1.43%452.11%1085.88%8510.39%
Mar 31, 2025221-1.78%86,577,050-12.78%471.59%104-20.00%7839.29%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity OTC4.68M2.53%-
Invesco Emerging Markets Equity2.69M1.46%-277.61K
Invesco Developing Markets A2.69M1.46%-
Fidelity Select Health Care2.60M1.41%-200.00K
Fidelity Select Pharmaceuticals Port2.52M1.36%-76.10K
Fidelity Growth Compy Commingled Pl O2.43M1.32%-
T. Rowe Price US Growth Stock Composite2.32M1.26%-77.22K
T. Rowe Price Growth Stock2.27M1.24%-32.51K
Fidelity VIP Contrafund Initial2.14M1.16%-
Jupiter Merian Glb Eq AbsRet I USD Acc2.09M1.13%2.09M

Recent Insider Transactions


DateNameRoleActivityValue
Mar 25, 2026Huang Ying Chief Executive OfficerSell$87.14K

Insider Transactions Trends


DateBuySell
2026 Q1-1

LEGN Ownership FAQ


Who Owns Legend Biotech?

Legend Biotech shareholders are primarily institutional investors at 14.81%, followed by 1.31% insiders and 83.88% retail investors. The average institutional ownership in Legend Biotech's industry, Biotech Stocks , is 35.75%, which Legend Biotech falls below.

Who owns the most shares of Legend Biotech?

Legend Biotech’s largest shareholders are Fmr (25.7M shares, 13.91%), Deerfield management company, l.p. (series c) (7.69M shares, 4.16%), and Suvretta capital management (7.58M shares, 4.10%). Together, they hold 22.18% of Legend Biotech’s total shares outstanding.

Does Blackrock own Legend Biotech?

Yes, BlackRock owns 3.14% of Legend Biotech, totaling 5.72M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 253.4M$. In the last quarter, BlackRock increased its holdings by 337.25K shares, a 6.26% change.

Who is Legend Biotech’s biggest shareholder by percentage of total assets invested?

Ivyrock asset management (hk) is Legend Biotech’s biggest shareholder by percentage of total assets invested, with 8.17% of its assets in 804K Legend Biotech shares, valued at 14.54M$.

Who is the top mutual fund holder of Legend Biotech shares?

Fidelity OTC is the top mutual fund holder of Legend Biotech shares, with 2.53% of its total shares outstanding invested in 4.68M Legend Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools